Akers Biosciences Inc (AKER): John J Gormally , Chief Executive Officer of Akers Biosciences Inc purchased 2,500 shares on May 24, 2016. The Insider buying transaction was reported by the company on May 24, 2016 to the Securities and Exchange Commission. The shares were purchased at $2.22 per share for a total value of $5,566.86 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jan 6, 2016, Raymond Francis Jr Akers (Executive Chairman, Secretary) purchased 2,100 shares at $1.34 per share price.On Dec 14, 2015, Gary M Rauch (VP – Finance, Treasurer) purchased 3,500 shares at $1.50 per share price.
Shares of Akers Biosciences Inc (AKER) ended Friday, May 20, 2016 session in red amid volatile trading. The shares closed down -0.12 points or -6.49% at $1.73 with 13,471 shares getting traded. Post opening the session at $1.91, the shares hit an intraday low of $1.65 and an intraday high of $1.91 and the price vacillated in this range throughout the day. The company has a market cap of $9,385 M and the number of outstanding shares has been calculated to be 5,42,50,00,000 shares. The 52-week high of Akers Biosciences Inc is $4.87 and the 52-week low is $1.08.